GENEDIA W COVID-19 IgM/IgG device is a chromatographic immunoassay kit for the rapid and differential detection of immunoglobulin M (lgM) and immunoglobulin G (IgG) against COVID-19 using serum, plasma and whole blood. Allow wider testing with fast test time (10 minutes) Perform directly at the point of care High capacity to meet the most urgent medical and public health needs Package Unit : 20 Tests/Kit Expiration Date : 24 Months
25 Piece SKU: 4314-25 EAN: 4250415677038 clinical specificity = 100 % clinical Sensitivity = 98,5 % BfArM approval fast and reliable test results in only 15 minutes can be performed with naso- and oropharyngeal samples all test components are included
Antigen Rapid COVID 19 Test Simple nasal swab or nasopharyngeal swab under 30 minutes Sensitivity 97.10% TCID50 75.5 CE marked for diagnostic use in EU and associated countries Paul Ehrlich Institute and IVD Min order 10000 pcs Free delivery within Germany
[ZENITH GROUP] COVID-19 Test Kit o Product Name - PCL COVID-19 AG Test Kit(Salvia) - PCL COVID-19 lgG/lgM o Price (USD) : 3.2$ (FOB) - Can be discussed up to order Qty - 10,000 : 3.2$ - 100,000 : 3.0$ - 1,000,000 : 2.8$ o MOQ : 10,000 pcs o Payment : 100% L/C at sight, irrevocable, transferable LC o Delivery Time- Up to Qty- Capacity : 3,000,000pcs / 1week
covid tests
Coivd Rapid Antigent Test kit Covid Rapid Antibody (Neutralizing) Test Kits CE certified For more discussion, please contact me
Cat No : COVAG025. GenBody COVID-19 Ag is an immunochromatographic assay kit for the qualitative detection of SARS-CoV-2 antigen in nasopharyngeal and oropharyngeal swab from human.
CAT No : Q-NCOV-01G. STANDARD Q COVID-19 Antigen Test kit is chromatographic immunoassay for the qualitative detection of SARS CoV 2 nucleocapsid antigen present in human nasal sample.
Till now we already exported 20 million tests and we can promise you very high quality. 25 tests/box, CE Mark and ISO, Clinical report, Certificate of analysis (COA) available Clinical specify >98.89% Accuracy: 93.41% Specimen: whole blood/serum, 10 minutes to get results
Rapid 2019-nCoV IgG/IgM Combo Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood. Rapid 2019-nCoV IgG/IgM Combo Test Card is a supplement detection for COVID-19 suspected infected patients besides nucleic acid test, which could greatly raise the accuracy of the detection for COVID-19. 25 tests/box, CE Mark and ISO, Clinical report, Certificate of analysis (COA) Clinical specify >98.89% Accuracy: 93.41% Specimen: whole blood/serum, 10 minutes to get results
Hi need covid-19 igg/igm rapid tear cassette? Promise you very high quality, and till now we already export more than 20 million tests and our Europe client said our product this way: you are the brain the world
COVID-19 Ag Rapid Test Device A RAPID TEST FOR THE QUALITATIVE DETECTION OF NOVEL CORONAVIRUS ANTIGENS IN NASAL SWAB AND NASAL ASPIRATE SPECIMENSS. Relative sensitivity: 84.4% Relative specificity: >99% Overall agreement: 97.8% Specimen: swab, 10-20 minutes to get results
Intended use: AIVD COVID-19(SARS-CoV-2) IgG/IgM Rapid Test is a single use, rapid device for qualitative detection of total antibodies against 2019 novel coronavirus (SARS-CoV-2) in human serum, plasma or whole blood specimens. The kit is intended for screening of patients suspected for infection with SARS-CoV-2, and as an aid in the diagnosis of the coronavirus disease 2019 (COVID-19). Descriptionï¼? Novel coronavirus pneumonia (NCP) or SARS-COV-2, that was officially named by the WHO as â??Corona virus disease 2019â?? (COVID-19), is a respiratory infection caused by a new virus that was first identified in late 2019. IgM/IgG Rapid Kit can specifically detect IgM and IgG antibodies of COVID-19, covering the entire course of infection and recovery period of patients. This approach improves the overall diagnosis of COVID-19 in both acute and recovery phases of illness. This kit utilizes the principle of colloidal gold immunochromatography to qualitatively detect the new coronavirus (COVID-19) IgG / IgM antibodies in human serum and plasma. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of COVID-19 suspected patients. This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well, and then add the required amount of a diluent. The IgG / IgM antibodies in the sample will interact with the colloidal gold-labeled COVID-19 recombinant antigen on the conjugate pad. Then the conjugate pad will release re-solubilized conjugate onto the nitrocellulose membrane. The nitrocellulose membrane (NC membrane) diffuses it forward. As the sample moves along the device binding reagents situated on the nitrocellulose membrane bind to the target at the test line. If the sample contains a COVID-19 IgG antibodies, they will bind to the colloidal gold-labeled novel coronavirus recombinant antigen, diffuse forward, and then react with the anti-human IgG antibodies immobilized on the NC membrane detection line (T2 line). Similarly, if the specimen contains IgM antibodies to COVID-19, the antibodies will react with antigen-coated particles, the conjugate migrate laterally forward, and cause a colored line (T1 line). The darker the color of colloidal gold on the test line, the higher the concentration antibodies to COVID-19 in the sample. Accuracy:ï¼?> 90% Specificity: 97% Basic Protocolï¼? 1. Remove the test specimen, required reagents from storage conditions, and equilibrate to room temperature. 2. Unpack the aluminum foil bag, place the test horizontally on the table and number it. 3. Add 10ul serum, plasma or whole blood sample to the sample well with a pipette or a dropper. Slowly add 2 drops of sample dilution (about 60uL) to the sample well. 4. Read the results within 10-15 minutes after adding the sample, and the results will be invalid after 30 minutes.
AIVD Biotechs COVID-19 Ag test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein (NP) antigen from SARS-CoV-2 in direct nasal swabs from individuals suspected of COVID-19. Description This kit utilizes the principle of latex bead immunochromatography to qualitatively detect the new coronavirus (COVID-19) Np antigen in human nasal swabs. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of COVID-19 suspected patients. The test contains latex bead conjugate pad and a membrane strip pre-coated with antibodies specific to SARS-CoV-2 antigen on the test lines (T). If SARS-CoV-2 antigen is present in the specimen, a visible band appears on the test lines (T) as antibody-antigen-antibody latex bead complex forms. The control line (C) is used for procedural control and should always appear if the test is performed correctly. This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well. If sample contains the antigen, it will interact with the latex bead-labeled COVID-19 anti-SARS-COV-2 NP antibodies on the conjugate pad. Required components 1. A foil pouch with a desiccant and a single-use test card, 1 piece 3. Sterile swab, 1 piece 3. Extraction buffer tube (1 ml), 1 tube. 4. Instructions for use, 1 piece. Specimen requirements: 1. Nasopharyngeal swab specimen. 2.Specimen should be tested as soon as possible upon collection. If the sample has to be stored, store the swab sample at room temperature for up to 1 hour or 2~8â?? for up to 4 hours prior to testing. Specimen preparation 1. Insert the extraction buffer tube into the tube rack, make sure that the sample tube is firmly upright and touches the bottom of the rack. 2. Insert the swab into an extraction buffer tube. 3. Gently stir the swab in the tube, and then left swab inside the tube for 1 minute or Mix on the vortex mixer for about 30 seconds, 4. The sample should be tested immediately after collection. If it cannot be tested in time, it should be stored in the virus transport matrix. The specimens can be stored at 2-8C for 4 hours Basic Protocol Step 1: If the sample is refrigerated, remove the sample to be tested and the required reagents from the storage conditions, equilibrate to room temperature (15~30C) Step 2: When preparing to test, open the aluminum foil bag, take out the test card, and lay it flat on a table. Step 3: Mark the sample number on the test card, Step 4: Using pipette add 50ul of the sample into a sample well on the device, Step 5: Read the result within 15 minutes, Please read the result after 15 minutes. After observing and recording the result, please discard the test card to avoid affecting the result judgment. Do not read test results after 30 minutes. It may give false results.
Covid 19 antigen rapid test kit , pregnancy test , ovulation test.
Us manufactured covid diagnostics .
Pcr covid test kits and etc.
We supply all things PPE: Covid Antigen & Antibody Test Kits: Nasal swab, oral swab and finger stick tests; Nitrile Gloves, Vgloves, Top Gloves; Face Shields; 3-ply masks; reusable masks; Gowns, shoe and head covers; thermometers, hand sanitizer.� Also, we are able to supply Covid supply VENDING MACHINES, disinfectant sprays and wipes; disinfectant fogger machines and sprayers.� We currently supply US distributors and medical supply companies coast-to-coast. (Top Quality/Extreme Wholesale). Contact us with your immediate requirement. Tell us what you want, bring us your target price. Satisfaction GUARANTEED! We look forward to working with you. We move a lot of quality products fast, so contact us IMMEDIATELY and join our team!!
Offering Safecare3 Covid 19 antigen + A+B flue, 1:3 combo tests, single packed, self testing, 2 years self time from my warehouse in Vilnius, Lithuania.
Access Bio Covid 19 Antigen Test Kit Care Start The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare providers.
